Written by Leticia Martínez and René Tamayo León A three-dose regimen of Cuba’s Abdala candidate vaccine has demonstrated an efficacy of 92.28 percent, placing it well above the World Health Organization (WHO) requirement of at least 50 percent, to be recognized as an anti-COVID-19 vaccine. Over the course of 48 hours, from Saturday to Monday, Cuba, a small, poor country,[Read More...]
The post Abdala, with three doses, has 92.28% efficacy in fighting COVID-19 appeared first on Countercurrents.
Source